Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20051435HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20051277HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20035648HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20014193HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20051335HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44023476HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44020669HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44023477HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44014539HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44041242HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB04879
Drug NameVatalanib
Target IDBE0000029
UniProt IDP17948
Regulation Type
PubMed IDs17584317
CitationsYamamoto A, Watanabe H, Sueki H, Nakanishi T, Yasuhara H, Iijima M: Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. J Dermatol. 2007 Jul;34(7):419-29.
GroupsInvestigational
Direct ClassificationPhthalazines
SMILESClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
PathwaysVatalanib Action Pathway
PharmGKBPA7001
ChEMBLCHEMBL101253